| Megan Bristol, MSN, RN, CNM | |
|
400 S Clark St, Butte, MT 59701-2328 | |
| (406) 496-3627 | |
| Not Available |
| Full Name | Megan Bristol |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 3 Years |
| Location | 400 S Clark St, Butte, Montana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689327165 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 192107 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St James Healthcare | Butte, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Scl Health Medical Group-butte Llc | 2466633102 | 80 |
News Archive
Breast cancer, even at its initial stages, could be detected earlier and more accurately than current techniques using blood samples and a unique proteomics-based technology, according to findings of a study led by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.
According to the United States Department of Agriculture, about half of U.S. children between birth and age 5 receive services from the Special Supplemental Nutrition Program for Women, Infants and Children.
The Tennessee Biotechnology Association and its Graduate Alliance are jointly hosting an afternoon of biotech, business, and law on December 7th, 2009. This event will be held at Belmont University with a reception at 5pm sponsored by i3 Research.
Transgenomic, Inc. (OTCBB: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, and Horizon Discovery Ltd. (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announced they have entered into a collaboration agreement to develop improved genetic diagnostic tests incorporating state of the art controls.
An increase in breast density appears to be the culprit behind an increase of breast cancer found in women participating in the estrogen and progestin therapy study, a part of the Women's Health Initiative (WHI). That is the finding of a new WHI analysis led by Celia Byrne, PhD, assistant professor at Georgetown Lombardi Comprehensive Cancer Center, and presented during the AACR 101st Annual Meeting 2010 in Washington, DC.
› Verified 2 days ago
| Entity Name | Scl Health Medical Group-butte Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477869600 PECOS PAC ID: 2466633102 Enrollment ID: O20110301000023 |
News Archive
Breast cancer, even at its initial stages, could be detected earlier and more accurately than current techniques using blood samples and a unique proteomics-based technology, according to findings of a study led by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.
According to the United States Department of Agriculture, about half of U.S. children between birth and age 5 receive services from the Special Supplemental Nutrition Program for Women, Infants and Children.
The Tennessee Biotechnology Association and its Graduate Alliance are jointly hosting an afternoon of biotech, business, and law on December 7th, 2009. This event will be held at Belmont University with a reception at 5pm sponsored by i3 Research.
Transgenomic, Inc. (OTCBB: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, and Horizon Discovery Ltd. (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announced they have entered into a collaboration agreement to develop improved genetic diagnostic tests incorporating state of the art controls.
An increase in breast density appears to be the culprit behind an increase of breast cancer found in women participating in the estrogen and progestin therapy study, a part of the Women's Health Initiative (WHI). That is the finding of a new WHI analysis led by Celia Byrne, PhD, assistant professor at Georgetown Lombardi Comprehensive Cancer Center, and presented during the AACR 101st Annual Meeting 2010 in Washington, DC.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Megan Bristol, MSN, RN, CNM 451 Little Basin Creek Rd, Butte, MT 59701-9612 Ph: (406) 498-1128 | Megan Bristol, MSN, RN, CNM 400 S Clark St, Butte, MT 59701-2328 Ph: (406) 496-3627 |
News Archive
Breast cancer, even at its initial stages, could be detected earlier and more accurately than current techniques using blood samples and a unique proteomics-based technology, according to findings of a study led by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.
According to the United States Department of Agriculture, about half of U.S. children between birth and age 5 receive services from the Special Supplemental Nutrition Program for Women, Infants and Children.
The Tennessee Biotechnology Association and its Graduate Alliance are jointly hosting an afternoon of biotech, business, and law on December 7th, 2009. This event will be held at Belmont University with a reception at 5pm sponsored by i3 Research.
Transgenomic, Inc. (OTCBB: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, and Horizon Discovery Ltd. (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announced they have entered into a collaboration agreement to develop improved genetic diagnostic tests incorporating state of the art controls.
An increase in breast density appears to be the culprit behind an increase of breast cancer found in women participating in the estrogen and progestin therapy study, a part of the Women's Health Initiative (WHI). That is the finding of a new WHI analysis led by Celia Byrne, PhD, assistant professor at Georgetown Lombardi Comprehensive Cancer Center, and presented during the AACR 101st Annual Meeting 2010 in Washington, DC.
› Verified 2 days ago
Rebecca Marie Lopez, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 445 Centennial Ave, Butte, MT 59701 Phone: 406-723-4075 Fax: 406-723-3059 | |
Jamie B. Glenn, CNM, MS Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 401 S Alabama St, Suite 1, Butte, MT 59701 Phone: 409-723-8051 Fax: 406-723-8063 | |
Jenevieve Lee Clark, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 400 S Clark St, Butte, MT 59701 Phone: 406-723-2500 |